H.R. 4076 - Counterfeit Drug Enforcement Act of 2007
- Sponsor:
- Steve Israel
- Summary:
- Status:
- The bill has been introduced.
Counterfeit Drug Enforcement Act of 2007
H.R. 4076 — 110th Congress (2007–2008)
- Summary
- To amend the Federal Food, Drug, and Cosmetic Act to increase criminal penalties for the sale or trade of prescription drugs knowingly caused to be adulterated or misbranded, to modify requirements for maintaining records of the chain-of-custody of prescription drugs, to establish recall authority regarding drugs, and for other purposes. (by CRS)
- Learn More
- At OpenCongress
- Title
- To amend the Federal Food, Drug, and Cosmetic Act to increase criminal penalties for the sale or trade of prescription drugs knowingly caused to be adulterated or misbranded, to modify requirements for maintaining records of the chain-of-custody of prescription drugs, to establish recall authority regarding drugs, and for other purposes.
- Other Titles
- Counterfeit Drug Enforcement Act of 2007
- Tim Fagan's Law
- Sponsor
- Steve Israel
- Co-Sponsors
- Subjects
- Medicine
- Administrative procedure
- Administrative remedies
- Business
- Business records
- Communication in medicine
- Communications
- Consumer protection
- Consumers
- Criminal investigation
- Criminal justice
- Criminal justice information
- Deceptive advertising
- Defective products
- Department of Health and Human Services
- Directories
- Drug adulteration
- Drug industry
- Drugs
- Executive departments
- Fines (Penalties)
- Food and Drug Administration (FDA)
- Government information
- Government paperwork
- Government publicity
- Governmental investigations
- Health education
- Identification devices
- Informers
- Intellectual property
- Labeling
- Law
- Medical care
- Medical personnel
- Packaging
- Product counterfeiting
- Subpoena
- Technology
- Wholesale trade
- Related Bills
- Major Actions
Introduced 11/05/2007 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 11/05/2007 11/05/2007 Referred to the House Committee on Energy and Commerce. Number Sponsor Date Offered Status
MapLight did not identify any interest groups that took a position on this vote.
You may be able to explore campaign contributions data if you add interest groups.
Help your colleagues by suggesting an organization that took a position on this vote.
Contributions data source: OpenSecrets.org
